Page last updated: 2024-10-27

gliclazide and Retinal Neovascularization

gliclazide has been researched along with Retinal Neovascularization in 1 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to assess the potential beneficial effects of gliclazide and other sulphonylureas on ischemia-induced retinal neovascularization."3.74Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization. ( Kimura, T; Kita, M; Suzuma, K; Takagi, H; Watanabe, D; Yoshimura, N, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimura, T1
Takagi, H1
Suzuma, K1
Kita, M1
Watanabe, D1
Yoshimura, N1

Other Studies

1 other study available for gliclazide and Retinal Neovascularization

ArticleYear
Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization.
    Free radical biology & medicine, 2007, Aug-01, Volume: 43, Issue:3

    Topics: Acetylcysteine; Animals; Blood Glucose; Female; Gliclazide; Glyburide; Ischemia; Mice; Oxidative Str

2007